Mode
Text Size
Log in / Sign up

Mini review examines genetic polymorphisms and viral markers linked to nasopharyngeal carcinoma risk

Mini review examines genetic polymorphisms and viral markers linked to nasopharyngeal carcinoma risk
Photo by Ekke Krosing / Unsplash
Key Takeaway
Note consistent EBV associations and genetic polymorphisms in NPC, but HPV links remain unconfirmed.

This publication is classified as a mini review focusing on the etiological factors of nasopharyngeal carcinoma. The authors synthesize existing literature concerning genetic susceptibility and viral exposures without reporting a specific study population or sample size. The scope encompasses host genetic polymorphisms and viral markers implicated in disease pathogenesis and risk assessment. The review does not detail specific inclusion criteria.

Regarding genetic associations, the review identifies polymorphisms in GSTM1, CYP1A1, XRCC1, TNF, and HLA microsatellites. Xenobiotic metabolism genes, particularly CYP2A6, are noted as significant contributors to susceptibility. Additionally, markers linked to Epstein-Barr virus, including LMP1, EBNA1, and circulating plasma EBV DNA, exhibited a consistent association with nasopharyngeal carcinoma susceptibility.

In contrast, associations regarding high-risk human papillomavirus markers have not yet been discovered in regard to nasopharyngeal carcinoma. The authors do not report safety data, adverse events, or practice relevance. Limitations regarding the certainty of evidence or funding sources are also not reported within the provided text.

Clinicians should recognize these findings as synthesized observations rather than definitive causal evidence. The absence of pooled effect sizes or confidence intervals limits quantitative interpretation of the reported associations. Further research is necessary to clarify the clinical implications of these genetic and viral markers for patient management. Current evidence does not support immediate changes to standard care protocols based solely on this review. Interpretation of these data requires caution.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
Nasopharyngeal carcinoma (NPC) are geographically restricted malignancies, exhibiting significantly higher incidence in specific regions and among certain ethnic groups, indicating strong genetic and region-specific etiological influences. The pathogenesis of these malignancies illustrates a multifaceted interaction involving host genetic predisposition, viral infections, as well as various environmental and lifestyle factors. This mini review brings together existing evidence regarding the molecular genetic factors influencing both EBV and HR-HPV-associated NPC, focusing on gene polymorphisms, viral biomarkers, and risk modifiers that vary across populations. Recurrent genetic associations involved polymorphisms in GSTM1, CYP1A1, XRCC1, TNF, HLA microsatellites, and xenobiotic metabolism genes, particularly CYP2A6. Markers linked to EBV, including LMP1, EBNA1, and circulating plasma EBV DNA, exhibited a consistent association with NPC susceptibility. Similarly, HR-HPV markers including E6 and E7 oncoproteins, p16INK4a overexpression, and HPV DNA detection serve as critical biomarkers for HPV-driven HNCs, but categorically these associations haven’t yet been discovered in regard to NPC. These findings classify NPC as a genetically modified, virus-related cancer and highlight the necessity for population-specific genetic risk assessment, EBV/HPV-derived biomarkers, and targeted preventative efforts.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.